South Africa: Biovac signs deal to manufacture oral cholera vaccine
November 24, 2022
JOHANNESBURG, Nov 24 (NNN-SANEWS) — South African-based bio-pharmaceutical company, Biovac, has concluded a ground-breaking licensing and technology transfer agreement to manufacture an oral cholera vaccine